How Dividendology’s view on $AVGO changed

2026-09-18Bullish
“3 Undervalued Dividend Stocks to Buy Now!”
Broadcom's valuation is attractive; projected 80% total return by 2028 supports a bull thesis.

The second stock on this month's list is Broadcom, and if you've been following the channel for a while, you know that this is a stock I've held in my portfolio for a long time, and I've continued to add capital over the years.

What is interesting is that if you look at my position in Broadcom's growth, you can see that I made a profit of over 180% on my average cost basis , but on my original shares, I made a profit of over 500%, possibly as high as 600%.

But I continued to add new capital to this center.

2026-09-09Bullish
“I Just Bought 2 Undervalued Dividend Growth Stocks!”
AVGO is undervalued relative to its strong earnings growth; the speaker is adding to his position.

If you have been following the channel for a while, you know that I have performed excellently with Broadcom stock, which I have held in my investment portfolio for a long time.

If you look at this stock in my growth chart, you will find that I have made a profit of approximately 198% based on the stock's average value. Based on the value of my original shares, I made a profit of approximately 600% .

So, when you look at a stock like Broadcom and notice that it has risen by 645% over the past five years, you might think that you have missed the opportunity. At least, that's what our investment inclination drives us to do.

However, if we look closely at the company's details, we will find evidence of the strength of its business quality, its continued strong growth, and its reasonable valuation, all while it continues to increase its dividend payouts.

2026-09-04Bullish
Subscribe or start a trial to unlock this step
2026-09-01Bullish
Subscribe or start a trial to unlock this step
2 earlier entries need a subscription
The latest 2 are free to read. Earlier entries keep their date and direction; the text unlocks with a subscription.
Subscribe · 30-day full trial